Establishing a model of HIV infection in macrophages to assess HIV / HBV co-infection driven liver disease
Alexis C. Brantly
Doctor of Philosophy (Ph.D.), Drexel University
Jul 2025
DOI:
https://doi.org/10.17918/00011134
Files and links (1)
pdf
Brantly_Alexis_20254.17 MB
PDF Embargoed Access, Embargo ends: 31 Aug 2027
Abstract
HBV HIV HIV HBV co-infection Liver macrophages Macrophages Viral kinetics
Safe and effective antiviral therapies (AT) have significantly improved outcomes for people with human immunodeficiency virus (HIV) (PWH) and people with hepatitis B virus (HBV). However, these treatments are not curative and individuals with either virus remain at increased risk for liver-related complications, such as hepatocellular carcinoma (HCC). Co-infection increases this risk, as PWH and HBV tend to develop HCC at a younger age, present with more advanced liver disease, and have shorter survival times than the general population. The mechanisms by which HIV/HBV co-infection accelerates liver disease remain poorly defined. Enhanced liver pathology may result from persistent immune activation, chronic inflammation, and exposure to viral proteins not eliminated by current therapies. Macrophages infected with HIV secrete a variety of viral proteins, and hepatocytes infected with HBV secrete high quantities of the envelope protein HBsAg into the bloodstream, even in the absence of active replication. To investigate this, we developed a multiparametric assay pipeline to study HIV infection in multiple types of human myeloid cells. Using this pipeline, we modeled co-infection by exposing HIV-infected macrophages to HBV-derived proteins. Treatment with HBsAg led to serotype-dependent effects on HIV replication, viral protein production, and macrophage cytokine responses, including alterations in IL-1[beta] and TNF-[alpha] levels. These data suggest that circulating HBV proteins influence HIV replication and immune activation within myeloid cells. These results provide novel insight into how HBV may exacerbate HIV-associated liver disease and underscore the importance of understanding macrophage responses in the context of viral co-infection.
Metrics
6 Record Views
Details
Title
Establishing a model of HIV infection in macrophages to assess HIV / HBV co-infection driven liver disease
Creators
Alexis C. Brantly
Contributors
Michael R. Nonnemacher (Advisor)
Peter J. Gaskill (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Doctor of Philosophy (Ph.D.)
Publisher
Drexel University; Philadelphia, Pennsylvania
Number of pages
xvi, 246 pages
Resource Type
Dissertation
Language
English
Academic Unit
Microbiology and Immunology; College of Medicine; Drexel University
Other Identifier
991022080355604721
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services